Recepta Biopharma SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Recepta Biopharma SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10883
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ブラジル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Recepta Biopharma SA (Recepta) is a biotechnology company that offers research and development of drugs used in the treatment of cancer. The company offers antibodies and peptide products. It offers antibodies such as monoclonal antibody hu3s193 – anti-ley, monoclonal antibody 58-1066 – anti-leb, monoclonal antibody mx35, and monoclonal antibody a34. Recepta conducts research at different stages of development to produce other mAbs for the treatment of cancer. The company partners with cancer research institutes, medical faculties, hospital centers and laboratories. Recepta is headquartered in Itaim Bibi, Brazil.

Recepta Biopharma SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Recepta Biopharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
BNDES Invests USD14.5 Million in Recepta Biopharma 10
Partnerships 11
4-Antibody And Ludwig Institute Enter Into Agreement With Recepta Biopharma For Oncology Research 11
Licensing Agreements 12
Mersana Therapeutics Enters into Licensing Agreement with Recepta Biopharma 12
Recepta Biopharma SA – Key Competitors 13
Recepta Biopharma SA – Key Employees 14
Recepta Biopharma SA – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Key Facts 2
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Recepta Biopharma SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Recepta Biopharma SA, Deals By Therapy Area, 2012 to YTD 2018 8
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BNDES Invests USD14.5 Million in Recepta Biopharma 10
4-Antibody And Ludwig Institute Enter Into Agreement With Recepta Biopharma For Oncology Research 11
Mersana Therapeutics Enters into Licensing Agreement with Recepta Biopharma 12
Recepta Biopharma SA, Key Competitors 13
Recepta Biopharma SA, Key Employees 14

List of Figures
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Recepta Biopharma SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Recepta Biopharma SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China International Water & Electric Corp:企業の戦略的SWOT分析
    China International Water & Electric Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Luminex Corp (LMNX)-医療機器分野:企業M&A・提携分析
    Summary Luminex Corp (Luminex) is a medical devices company which develops, manufactures and markets proprietary biological testing technologies. The company offers wide range of products including instruments, assays, reagents and accessories, software and replacement parts. Its proprietary technol …
  • RED HAT, INC.:企業の戦略・SWOT・財務情報
    RED HAT, INC. - Strategy, SWOT and Corporate Finance Report Summary RED HAT, INC. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329)-製薬・医療分野:企業M&A・提携分析
    Summary Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TZPG) manufactures and markets traditional Chinese medicine, western medicine and health products. The company offers Chinese patent medicines, Chinese medicinal materials, western medicines, dietary supplements, pharmaceutical raw materials an …
  • Perficient Inc (PRFT):企業の財務・戦略的SWOT分析
    Perficient Inc (PRFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Energy Focus, Inc. (EFOI):電力:M&Aディール及び事業提携情報
    Summary Energy Focus, Inc. (Energy Focus) is a provider of energy efficient light-emitting diode (LED) lighting products and technologies. The company, together with its subsidiaries, designs, develops, manufactures, markets, and installs energy-efficient lighting systems and solutions. Its military …
  • Grupo Grana y Montero SAA (GRAMONC1):石油・ガス:M&Aディール及び事業提携情報
    Summary Grupo Grana y Montero SAA (Grana y Montero) is a group company that provides engineering and infrastructure services. The company’s business areas include engineering and construction, infrastructure development, real estate and technical services. It provides engineering procurement and con …
  • salesforce.com, inc.:企業のM&A・事業提携・投資動向
    salesforce.com, inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's salesforce.com, inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Barents Re Reinsurance Company, Inc.:企業の戦略・SWOT・財務分析
    Barents Re Reinsurance Company, Inc. - Strategy, SWOT and Corporate Finance Report Summary Barents Re Reinsurance Company, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Crohn’s & Colitis Foundation Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Crohn's & Colitis Foundation Inc (CCF) is a non-profit organization that provides treatments for crohn's disease and ulcerative colitis. The organization funds studies at medical institutions, nurture investigators, and finance underdeveloped areas of research. It provides clinical research …
  • Co-Diagnostics Inc-医療機器分野:企業M&A・提携分析
    Summary Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit …
  • NEC Corp (6701):企業の財務・戦略的SWOT分析
    NEC Corp (6701) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Nidek Co Ltd:企業の戦略的SWOT分析
    Nidek Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Gulf Investment Corporation:企業の戦略的SWOT分析
    Gulf Investment Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Wellcome Trust Sanger Institute-製薬・医療分野:企業M&A・提携分析
    Summary Wellcome Trust Sanger Institute (Sanger Institute), a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular and human genetics and infection genomics. It also provides postgraduate training on research …
  • Bharat Dynamics Limited:企業の戦略・SWOT・財務分析
    Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report Summary Bharat Dynamics Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Curevac AG-製薬・医療分野:企業M&A・提携分析
    Summary Curevac AG (Curevac), formerly CureVac GmbH is a clinical stage biopharmaceutical company that develops RNA-based medicines. The company designs, develops and produces messenger RNA molecules for therapeutic and prophylactic vaccines in the fields of oncology and infectious diseases. Its RNA …
  • Indianapolis Power & Light Co:電力:M&Aディール及び事業提携情報
    Summary Indianapolis Power & Light Co (IPL), a subsidiary of IPALCO Enterprises Inc, is an integrated electric utility. The company generates, transmits, distributes, and sells electric energy. It produces electricity from coal, oil, and natural gas sources. IPL owns and operates power plants in Ind …
  • IntegraGen SA (ALINT):製薬・医療:M&Aディール及び事業提携情報
    Summary IntegraGen SA (IntegraGen) is a developer and commercializer of molecular diagnostic tests for the treatment of autism and oncology. The company provides advanced genomic and bioinformatic services, including clinical research, basic and human genetic research, bioinformatics and bioanalysis …
  • PT. Bank Rakyat Indonesia (Persero) Tbk.:戦略・SWOT・企業財務分析
    PT. Bank Rakyat Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report Summary PT. Bank Rakyat Indonesia (Persero) Tbk. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆